Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.
November 2024 in “Advances in Pharmacology and Pharmacy” A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.
September 2024 in “International Journal of Applied Pharmaceutics” A reliable method was developed to measure Finasteride and Tadalafil in rat blood.
CCC1 is essential for ion balance and proper plant cell function.
3 citations
,
August 2022 in “Biochemical Genetics”
1 citations
,
July 2022 in “British Journal of Dermatology” Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.
26 citations
,
September 2009 in “Clinical genetics” Arab APS1 patients have unique and recurrent AIRE gene mutations.
2 citations
,
July 2025 in “Scientific Reports” Acinetobacter strain A1-4-2 can safely clean water pollutants.
14 citations
,
January 2025 in “Journal of Dermatological Treatment” Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.
May 2018 in “Journal of Sun Yat-sen University”
July 2024 in “Chinese Medical Journal” Peripheral blood alive cell treatment is effective and safe for treating hair loss.
January 2020 in “Juntendo Medical Journal” The document's conclusion cannot be determined as the content is not available.
September 2023 in “Zenodo (CERN European Organization for Nuclear Research)”
June 2019 in “Reactions Weekly”
Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.
November 2006 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not available.
November 2008 in “Hair transplant forum international” The document's conclusion cannot be determined.
January 2013 in “CINECA IRIS Institutial research information system (University of Pisa)”
May 2023 in “Indian journal of science and technology” The new deep learning system can accurately recognize hair loss conditions with a 95.11% success rate.
1 citations
,
June 2017 in “JAMA Dermatology” The document corrects a name misspelling, acknowledges a pioneer in hair transplantation, and notes a missing conflict of interest disclosure.
July 2018 in “Hair transplant forum international” The document's content couldn't be processed.
August 2025 in “Bioactive Materials” Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.
May 2025 in “BMC Genomics” Circ 0020938 slows down hair growth in cashmere goats.
April 2013 in “Dermatology and therapy” Crescina treatment improves hair resistance and reduces hair loss.
July 2025 in “Journal of the European Academy of Dermatology and Venereology” 130 citations
,
January 2000 in “Nature biotechnology”
September 2020 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not accessible.
November 2020 in “Journal of The American Academy of Dermatology” Nonsurgical treatments effective for hair loss in men and women.
January 2020 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not accessible.
81 citations
,
August 2011 in “Journal of The American Academy of Dermatology” Latanoprost 0.1% may effectively treat hair loss.